Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology Pharmaceutical Investing
Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study Pharmaceutical Investing
BioDelivery Sciences Announces Launch and Availability of BELBUCA® in Canada Pharmaceutical Investing
Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares Pharmaceutical Investing
AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program Pharmaceutical Investing
